Mistry PK - Search Results

1

Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1.

Cox TM, Charrow J, Lukina E, Mistry PK, Foster MC, Peterschmitt MJ. Cox TM, et al. Among authors: mistry pk. Genet Med. 2023 Feb;25(2):100329. doi: 10.1016/j.gim.2022.10.011. Epub 2022 Dec 5. Genet Med. 2023. PMID: 36469032 Free article.

2

Genetic diagnosis of Gaucher's disease.

Mistry PK, Smith SJ, Ali M, Hatton CS, McIntyre N, Cox TM. Mistry PK, et al. Lancet. 1992 Apr 11;339(8798):889-92. doi: 10.1016/0140-6736(92)90928-v. Lancet. 1992. PMID: 1348297

3

Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.

Mistry PK, Davies S, Corfield A, Dixon AK, Cox TM. Mistry PK, et al. Q J Med. 1992 Jul;83(303):541-6. Q J Med. 1992. PMID: 1484931

4

The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.

Mistry PK, Cox TM. Mistry PK, et al. J Med Genet. 1993 Nov;30(11):889-94. doi: 10.1136/jmg.30.11.889. J Med Genet. 1993. PMID: 8301642 Free PMC article. Review. No abstract available.

5

Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease.

Mistry PK, Wraight EP, Cox TM. Mistry PK, et al. Lancet. 1996 Dec 7;348(9041):1555-9. doi: 10.1016/S0140-6736(96)04451-0. Lancet. 1996. PMID: 8950883

6

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A. Charrow J, et al. Arch Intern Med. 2000 Oct 9;160(18):2835-43. doi: 10.1001/archinte.160.18.2835. Arch Intern Med. 2000. PMID: 11025794

7

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Zimran A. Weinreb NJ, et al. Am J Med. 2002 Aug 1;113(2):112-9. doi: 10.1016/s0002-9343(02)01150-6. Am J Med. 2002. PMID: 12133749

8

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Prakash-Cheng A, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ. Charrow J, et al. J Pediatr. 2004 Jan;144(1):112-20. doi: 10.1016/j.jpeds.2003.10.067. J Pediatr. 2004. PMID: 14722528 Review. No abstract available.

9

Therapeutic goals in the treatment of Gaucher disease.

Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, Grabowski GA, Mistry PK, Tylki-Szymańska A. Pastores GM, et al. Among authors: mistry pk. Semin Hematol. 2004 Oct;41(4 Suppl 5):4-14. doi: 10.1053/j.seminhematol.2004.07.009. Semin Hematol. 2004. PMID: 15468045 Review.

10

Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients.

Weinreb NJ, Aggio MC, Andersson HC, Andria G, Charrow J, Clarke JT, Erikson A, Giraldo P, Goldblatt J, Hollak C, Ida H, Kaplan P, Kolodny EH, Mistry P, Pastores GM, Pires R, Prakash-Cheng A, Rosenbloom BE, Scott CR, Sobreira E, Tylki-Szymańska A, Vellodi A, vom Dahl S, Wappner RS, Zimran A; International Collaborative Gaucher Group (ICGG). Weinreb NJ, et al. Semin Hematol. 2004 Oct;41(4 Suppl 5):15-22. doi: 10.1053/j.seminhematol.2004.07.010. Semin Hematol. 2004. PMID: 15468046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page